Press Releases


Latest News


Adamas Presents ADS-5102 Pooled Phase 3 Data Confirming Statistically Significant Reduction in Levodopa-Induced Dyskinesia and OFF Time in People with Parkinson's Disease
Apr 24, 2017 | General Releases

Adamas Announces Oral and Poster Presentations of ADS-5102 Pooled Phase 3 Data at the 69th American Academy of Neurology Annual Meeting
Apr 18, 2017 | General Releases

Adamas Announces Data Presentation on ADS-5102 at the Academy of Managed Care Pharmacy 2017 Annual Meeting
Mar 28, 2017 | General Releases

Adamas to Present at the 16th Annual Needham Healthcare Conference
Mar 28, 2017 | General Releases

Adamas Announces New Employment Inducement Grant
Mar 10, 2017 | General Releases

Adamas to Present at the 37th Annual Cowen Health Care Conference
Mar 1, 2017 | General Releases

Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2016
Feb 28, 2017 | General Releases

Adamas Presents Additional Open-Label, Long-Term Safety and Efficacy Data on ADS-5102 at the First Pan American Parkinson's Disease and Movement Disorders Congress
Feb 28, 2017 | General Releases

Adamas to Present New ADS-5102 Data from Phase 2 Trial in Walking Impairment Associated with Multiple Sclerosis at ACTRIMS Forum 2017
Feb 17, 2017 | General Releases

Adamas Outlines Key 2017 Priorities and Highlights 2016 Achievements
Jan 8, 2017 | General Releases

Pages:  1 2 3 4 5 6 7 8 9 10 11